Home › About Us
About Prime Path Lab
One laboratory. One building. One name on the report.
Prime Path Lab Inc. is a CLIA-certified, COLA-accredited clinical laboratory in Denver, Colorado. Specimens arrive here, are tested here, are analyzed here, and are reported from here.
Who we are
A diagnostics laboratory built around accountability.
Most laboratories ask a physician to trust a brand. We would rather they check a number. Ours is CLIA #06D2341973, and it is on every report we issue.
Certified and accredited
CLIA #06D2341973. COLA accredited. Testing performed at the Denver facility named on our certificate — not subcontracted, not referred out.
A named director
Wenbing Chen, Ph.D., NRCC-certified in Toxicological Chemistry, directs this laboratory. You can look him up. You can call him.
Nothing leaves the building
Sequencing, bioinformatics, secondary analysis, interpretation, and reporting are performed in-house by Prime Path staff.
Leadership
Wenbing Chen, Ph.D.
Laboratory Director · NRCC-certified in Toxicological Chemistry
Qualification
Certified by the National Registry of Certified Chemists, an HHS-approved board under 42 CFR 493.1443 for directors of high-complexity testing.
Availability
Available to ordering physicians for consultation on panel selection, result interpretation, and clinical decision support.
Scope
Directs toxicology, molecular infectious disease, and genomic testing performed at the Denver facility.
Quality & Compliance
What we can show you.
- Assay validation and ongoing performance verification
- Internal quality controls and proficiency testing
- In-house bioinformatics and secondary analysis pipeline for NGS
- Documented laboratory compliance program
- Panels constructed against current CMS coverage policy
| CLIA Certificate | #06D2341973 |
|---|---|
| Accreditation | COLA |
| Laboratory Director | Wenbing Chen, Ph.D. — NRCC-certified, Toxicological Chemistry |
| Testing Site | 6000 E Evans Ave, Ste 3-014, Denver, CO 80222 |
Talk to a scientist, not a call center.
Our toxicologists and molecular pathologists discuss results directly with ordering physicians.